MUNICH--(BUSINESS WIRE)--Ethris GmbH, a pioneer in the emerging field of messenger RNA (mRNA) therapies, announced today the addition of Dr. Leon Chen, Venture Partner with OrbiMed, Dr. Thomas Chalberg, COO of Oncorus, Inc. and Justin Duckworth, Managing Partner with HS Life Sciences, to the Ethris Board of Directors.
